2019 American Transplant Congress
Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation
Temple University Hospital, Philadelphia, PA
*Purpose: Minimal literature exists regarding alemtuzumab for induction in lung transplantation but is the preferred agent at Temple University Hospital (TUH). Basiliximab is reserved for…2019 American Transplant Congress
Infectious Complications of Eculizumab Use in Abdominal Organ Transplant Recipients
*Purpose: The purpose of this study is to identify and characterize infections in abdominal organ transplant recipients related to treatment with eculizumab. Eculizumab (Soliris®) is…2019 American Transplant Congress
Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients
Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Tocilizumab blocks IL-6 signaling, inhibiting maturation of B cells to plasma cells and antibody production. We have used tocilizumab since 2012 to treat kidney…2019 American Transplant Congress
Predictors of Clostridium difficile Infection and Recurrence among 2,622 Solid Organ Transplant Recipients
Columbia University, New York, NY
*Purpose: Clostridium difficile infection (CDI) is common after solid organ transplant (SOT) and is associated with high morbidity and mortality. We assessed incidence, risk factors…2019 American Transplant Congress
What is the Post-Heart Transplant Risk of Infectious Complications from Pre-Transplant Desensitization Therapy?
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Sensitization or the detection of circulating antibodies in heart transplant candidates appears to be increasing due to the growing use of mechanical circulatory support…2019 American Transplant Congress
Epidemiology and Risk Factors of Early Post-Transplant Clostridium difficile Infection in Renal Transplant Recipients
1UW Health, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: To elucidate the epidemiology and peri-transplant risk of CDI*Methods: Retrospective review of adult renal transplant (RTX) recipients from 1/1/2012-12/31/2015. Primary objective was to describe…2019 American Transplant Congress
Yellow Fever and Renal Transplantation: Influence of Vaccination and Infection on the Emergence of Antibody-Mediated Rejection
*Purpose: Yellow fever (YF) is a viral hemorrhagic disease transmitted by mosquitos, with variable clinical disease manifestations from a mild, undifferentiated febrile illness to severe…2019 American Transplant Congress
Spontaneous Bacterial Peritonitis Prophylaxis Increases the Risk of Multi-Drug Resistant Cultures and Infections in Liver Transplant Patients
Columbia University Medical Center, New York, NY
*Purpose: Spontaneous bacterial peritonitis prophylaxis (SBP-P) is increasingly prescribed to patients awaiting liver transplantation (LT), but its impact on multidrug resistant organisms (MDRO) or the…2019 American Transplant Congress
Improving Medication Adherence and Outcomes in Adult Kidney Transplant Patients Using SystemCHANGETM: Results of the Medication Adherence Given Individual Change (MAGIC) Randomized Clinical Trial
*Purpose: Medication non-adherence is an obdurate problem associated with poor outcomes and staggering costs. Even with multi-faceted interventions, effect sizes reported in meta-analyses of medication…2019 American Transplant Congress
Burden of Respiratory Virus Infections in Solid-Organ Transplant Recipients: A Nationwide Multi-Season Cohort Study
*Purpose: Respiratory virus infections (RVI) are common in solid-organ transplant recipients (SOTr) and are caused by a wide range of viruses. However, beside influenza, little…
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 84
- Next Page »